Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyronaridine/Artesunate Dose-Ranging in Uncomplicated P. falciparum Malaria
NCT01594931Phase 2Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Jul 2005
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of pyronaridine, artesunate in Plasmodium falciparum malaria, sponsored by Medicines for Malaria Venture. Started Jul 2005; status: completed.
02
Drugs
pyronaridineartesunate
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01594931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01594931.